Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.05 USD
Change Today -0.08 / -1.94%
Volume 1.5M
GERN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - geron corp (GERN)

Name (Connections)Board RelationshipsTitleKey Developments
Karin Eastham CPA 78 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Compensation Committee 
V. Lawlis Jr., Ph.D. 44 RelationshipsDirector, Member of Compensation Committee and Member of Audit Committee 
Daniel Bradbury 179 RelationshipsIndependent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 

Compensation Committee* - geron corp (GERN)

Name (Connections)Board RelationshipsTitle
Karin Eastham CPA 78 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Compensation Committee
V. Lawlis Jr., Ph.D. 44 RelationshipsDirector, Member of Compensation Committee and Member of Audit Committee
GERN Compensation vs. Industry
586.5K
360.3K
Chief Executive Officer
365.0K
263.9K
Chief Financial Officer
Share price activity for GERON CORP (GERN)
52 Week Price Performance
GERN
Industry Average

Nominating Committee* - geron corp (GERN)

Name (Connections)Board RelationshipsTitleKey Developments
Hoyoung Huh M.D., Ph.D. 114 RelationshipsChairman and Member of Nominating & Corporate Governance CommitteeGeron Corporation Announces Management Promotions
02/14/14
Susan Molineaux Ph.D. 61 RelationshipsDirector and Chairperson of Nominating & Corporate Governance CommitteeGeron Corporation Announces Executive Changes
05/24/13
Daniel Bradbury 179 RelationshipsIndependent Director, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeGeron Corporation Discontinues GRN1005, its Peptide-Drug Conjugate Designed to Treat Cancers in the Brain; Announces Executive Changes
12/3/12

Corporate Governance Committee* - geron corp (GERN)

Name (Connections)Board RelationshipsTitle
Daniel Bradbury 179 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Compensation Committee
Hoyoung Huh M.D., Ph.D. 114 RelationshipsDirector, Member of Compensation Committee and Member of Audit Committee
Susan Molineaux Ph.D. 61 Relationships--
GERN and Competitor
Insiders vs. External
Board
14%
86%
Geron Corporation
20%
80%
BioTime, Inc.
14%
86%
ReNeuron Group plc
11%
89%
StemCells Inc.
6%
94%
Ocata Therapeutics, Inc.
25%
75%
Neuralstem, Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GERN:US $4.05 USD -0.08

GERN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioTime Inc $3.16 USD -0.07
Neuralstem Inc $1.73 USD +0.03
Ocata Therapeutics Inc $4.49 USD +0.24
ReNeuron Group PLC 5.38 GBp -0.25
StemCells Inc $0.41 USD +0.0052
View Industry Companies
 

Industry Analysis

GERN

Industry Average

Valuation GERN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 529.9x
Price/Book 5.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 411.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GERON CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.